. Michel, Les événements indésirables graves dans les établissements de santé : fréquence, évitabilité et acceptabilité, Etudes et Résultats, vol.761, 2011.

G. Onder, T. Van-der-cammen, M. Petrovic, A. Somers, and C. Rajkumar, Strategies to reduce the risk of iatrogenic illness in complex older adults, Age and Ageing, vol.42, issue.3, pp.284-91, 2013.
DOI : 10.1093/ageing/aft038

A. Spinewine, Continuité du traitement médicamenteux entre l'hôpital et le domicile Health Services Research (HSR) Bruxelles : centre fédéral d'expertise des soins de santé (KCE) 2010

A. Forster, H. Murff, J. Peterson, T. Gandhi, and D. Bates, The Incidence and Severity of Adverse Events Affecting Patients after Discharge from the Hospital, Annals of Internal Medicine, vol.138, issue.3, pp.161-168, 2003.
DOI : 10.7326/0003-4819-138-3-200302040-00007

A. Forster, H. Clark, A. Menard, N. Dupuis, R. Chernish et al., Adverse events among medical patients after discharge from hospital, CMAJ Can Med Assoc J J Assoc Medicale Can Feb, vol.3, issue.1703, pp.345-354, 2004.

B. Glintborg, S. Andersen, and K. Dalhoff, Insufficient communication about medication use at the interface between hospital and primary care. Qual Saf Health Care, Feb, vol.16, issue.1, pp.34-43, 2007.

C. Van-walraven, R. Seth, P. Austin, and A. Laupacis, Effect of discharge summary availability during post-discharge visits on hospital readmission, Journal of General Internal Medicine, vol.122, issue.Supplement 2, pp.186-92, 2002.
DOI : 10.1046/j.1525-1497.2002.10741.x

A. Mudge, R. Shakhovskoy, and A. Karrasch, Quality of transitions in older medical patients with frequent readmissions: Opportunities for improvement, European Journal of Internal Medicine, vol.24, issue.8, pp.779-83, 2013.
DOI : 10.1016/j.ejim.2013.08.708

F. Karapinar-carkit, S. Borgsteede, J. Zoer, C. Siegert, M. Van-tulder et al., The effect of the COACH program (Continuity Of Appropriate pharmacotherapy, patient Counselling and information transfer in Healthcare) on readmission rates in a multicultural population of internal medicine patients, BMC Health Services Research, vol.25, issue.Suppl 4, p.39, 2010.
DOI : 10.2165/00019053-200725010-00004

K. Still, A. Davis, A. Chilipko, A. Jenkosol, and D. Norwood, Evaluation of a Pharmacy-Driven Inpatient Discharge Counseling Service: Impact on 30-Day Readmission Rates, The Consultant Pharmacist, vol.28, issue.12, 2013.
DOI : 10.4140/TCP.n.2013.775

E. Jean-bart, B. Charpiat, O. Conort, F. Rose, M. Juste et al., Formulation et contextualisation des avis accompagnant les interventions pharmaceutiques. Pharm Hosp Clin, pp.127-158, 2012.
DOI : 10.1016/j.phclin.2012.01.003

M. Laroche, F. Bouthier, M. L. Charmes, and J. , Potentially inappropriate medications in the elderly: a list adapted to French medical practice. Rev Médecine Interne Fondée Par Société Natl Francaise Médecine Interne, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00739843

S. Legrain, S. Consommation-médicamenteuse-chez-le, and . Agé, Consommation, Prescription, Iatrogénie et Observance ». HAS PMSA synthèse bibliographique, 2005.

G. Bouvenot and P. Villani, Apport des essais pré-AMM à la connaissance du risque iatrogène chez la personne âgée. Thérapie, pp.233-239, 2004.

D. Juurlink, M. Mamdani, A. Kopp, A. Laupacis, and D. Redelmeier, Drug-Drug Interactions Among Elderly Patients Hospitalized for Drug Toxicity, JAMA, vol.289, issue.13, pp.1652-1660, 2003.
DOI : 10.1001/jama.289.13.1652

E. Hajjar, J. Hanlon, M. Artz, C. Lindblad, C. Pieper et al., Adverse drug reaction risk factors in older outpatients, The American Journal of Geriatric Pharmacotherapy, vol.1, issue.2, pp.82-91, 2003.
DOI : 10.1016/S1543-5946(03)90004-3

T. Higashi, P. Shekelle, D. Solomon, E. Knight, C. Roth et al., The Quality of Pharmacologic Care for Vulnerable Older Patients, Annals of Internal Medicine, vol.140, issue.9, pp.714-734, 2004.
DOI : 10.7326/0003-4819-140-9-200405040-00011

D. Gnjidic and S. Hilmer, Emergency hospitalizations for adverse drug events, N Engl J Med. Mar, vol.1366, issue.9, pp.859-859, 2012.

J. Ankri, Le risque iatrogène médicamenteux chez le sujet âgé. Gérontologie Société, pp.93-106, 2002.
DOI : 10.3917/gs.103.0093

URL : http://www.cairn.info/load_pdf.php?ID_ARTICLE=GS_103_0093

J. Gurwitz, T. Field, L. Harrold, J. Rothschild, K. Debellis et al., Incidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting, JAMA, vol.289, issue.9, pp.1107-1123, 2003.
DOI : 10.1001/jama.289.9.1107

J. Hanlon, K. Schmader, C. Ruby, and M. Weinberger, Suboptimal Prescribing in Older Inpatients and Outpatients, Journal of the American Geriatrics Society, vol.34, issue.3, pp.200-209, 2001.
DOI : 10.1046/j.1532-5415.2001.49042.x

S. Legrain, Prescription to elderly patients: reducing underuse and adverse drug reactions and improving adherence. Bull Académie Natl Médecine, 2007.

B. Hayes, W. Klein-schwartz, and F. Barrueto, Polypharmacy and the Geriatric Patient, Clinics in Geriatric Medicine, vol.23, issue.2, pp.371-390, 2007.
DOI : 10.1016/j.cger.2007.01.002

D. Fusco, F. Lattanzio, M. Tosato, A. Corsonello, A. Cherubini et al., Development of CRIteria to Assess Appropriate Medication Use among Elderly Complex Patients (CRIME) Project, Drugs & Aging, vol.366, issue.5, 2009.
DOI : 10.2165/11534620-000000000-00000

S. Ferchichi and V. Antoine, Appropriate drug prescribing in the elderly. Rev Médecine Interne Fondée Par Société Natl Francaise Médecine Interne, 2004.

P. Queneau, B. Trombert, F. Carpentier, A. Trinh-duc, B. Bannwarth et al., Accidents m??dicamenteux, Annales Pharmaceutiques Fran??aises, vol.63, issue.2, pp.131-173, 2005.
DOI : 10.1016/S0003-4509(05)82263-1

P. Lang, Y. Hasso, J. Belmin, I. Payot, J. Baeyens et al., STOPP-START: adaptation of a French language screening tool for detecting inappropriate prescriptions in older people], Can J Public Health Rev Can Santé Publique, vol.100, issue.6, pp.426-457, 2009.

W. Himmel, M. Kochen, U. Sorns, and E. Hummers-pradier, Drug changes at the interface between primary and secondary care, Int. Journal of Clinical Pharmacology and Therapeutics, vol.42, issue.02, 2004.
DOI : 10.5414/CPP42103

W. Himmel, M. Tabache, and M. Kochen, What happens to long-term medication when general practice patients are referred to hospital?, European Journal of Clinical Pharmacology, vol.50, issue.4, pp.253-260, 1996.
DOI : 10.1007/s002280050103

T. Grimmsmann, U. Schwabe, and W. Himmel, The influence of hospitalisation on drug prescription in primary care ??? a large-scale follow-up study, European Journal of Clinical Pharmacology, vol.115, issue.8, pp.783-90, 2007.
DOI : 10.1007/s00228-007-0325-1

F. Karapinar, P. Van-den-bemt, J. Zoer, G. Nijpels, and S. Borgsteede, Informational needs of general practitioners regarding discharge medication: content, timing and pharmacotherapeutic advices, Pharmacy World & Science, vol.16, issue.6, 2010.
DOI : 10.1007/s11096-009-9363-3

P. Autier, M. Boniol, C. Pizot, and P. Mullie, Vitamin D status and ill health: a systematic review, The Lancet Diabetes & Endocrinology, vol.2, issue.1, pp.76-89, 2014.
DOI : 10.1016/S2213-8587(13)70165-7

URL : https://hal.archives-ouvertes.fr/hal-01262539

J. Larosa, J. He, and S. Vupputuri, Effect of Statins on Risk of Coronary Disease, JAMA, vol.282, issue.24, pp.2340-2346, 1999.
DOI : 10.1001/jama.282.24.2340

C. Baigent, A. Keech, P. Kearney, L. Blackwell, G. Buck et al., Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins, Lancet, vol.366, issue.9493, pp.1267-78, 2005.

D. Prato, S. Heine, R. Keilson, L. Guitard, C. Shen et al., Treatment of patients over 64 years of age with type 2 diabetes: experience from nateglinide pooled database retrospective analysis. Diabetes Care, pp.2075-80, 2003.

G. Booth, M. Kapral, K. Fung, and J. Tu, Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study, The Lancet, vol.368, issue.9529, pp.29-36, 2006.
DOI : 10.1016/S0140-6736(06)68967-8

J. Nelson, K. Dufraux, and P. Cook, The Relationship Between Glycemic Control and Falls in Older Adults, Journal of the American Geriatrics Society, vol.52, issue.(5, pp.2041-2045, 2007.
DOI : 10.1111/j.1532-5415.2007.01430.x

F. Ismail-beigi, E. Moghissi, M. Tiktin, I. Hirsch, S. Inzucchi et al., Individualizing Glycemic Targets in Type 2 Diabetes Mellitus: Implications of Recent Clinical Trials, Annals of Internal Medicine, vol.154, issue.8, pp.554-563, 2011.
DOI : 10.7326/0003-4819-154-8-201104190-00007

S. Inzucchi, R. Bergenstal, J. Buse, M. Diamant, E. Ferrannini et al., Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetes Care, 2012.

E. Arques-armoiry, D. Cabelguenne, C. Stamm, A. Janoly-dumenil, I. Grosset-grange et al., Problèmes médicamenteux les plus fréquemment détectés par l'analyse pharmacothérapeutique des prescriptions dans un centre hospitalier universitaire. Rev Médecine Interne, pp.804-815, 2010.
DOI : 10.1016/j.revmed.2010.08.001

P. Bedouch and B. Charpiat, Site internet de la Société Française de Pharmacie Clinique pour l'analyse des interventions pharmaceutiques: finalité, mode d'emploi et perspectives, J Pharm Clin, vol.26, pp.40-44, 2007.

T. Van-der-cammen, C. Rajkumar, G. Onder, C. Sterke, and M. Petrovic, Drug cessation in complex older adults: time for action, Age and Ageing, vol.43, issue.1, pp.20-25, 2014.
DOI : 10.1093/ageing/aft166

H. Garåsen and R. Johnsen, The quality of communication about older patients between hospital physicians and general practitioners: a panel study assessment, BMC Health Services Research, vol.319, issue.1, p.133, 2007.
DOI : 10.1136/bmj.319.7217.1127

R. Urban, E. Paloumpi, R. N. Morgan, and J. , Communicating medication changes to community pharmacy post-discharge: the good, the bad, and the improvements, International Journal of Clinical Pharmacy, vol.165, issue.4
DOI : 10.1007/s11096-013-9813-9

A. Munday, B. Kelly, J. Forrester, A. Timoney, E. Mcgovern et al., Do general practitioners and community pharmacists want information on the reasons for drug therapy changes implemented by secondary care?, pp.563-569, 1997.

K. Brookes, M. Scott, and J. Mcconnell, The benefits of a hospital based community services liaison pharmacist, Pharmacy World and Science, vol.22, issue.2, pp.33-41, 2000.
DOI : 10.1023/A:1008713304892

F. Paille, Over-consumption of drugs by elderly patients]. Thérapie, 2004.

D. Stange, L. Kriston, V. Wolff, A. Baehr, M. Dartsch et al., Medication complexity, prescription behaviour and patient adherence at the interface between ambulatory and stationary medical care, European Journal of Clinical Pharmacology, vol.12, issue.3, 2013.
DOI : 10.1007/s00228-012-1342-2